Hook & thesis
Robert Half has been beaten down during a difficult year for staffing stocks, but the firm is showing the early signs of a cyclical lift. Management already called out sequential momentum in talent solutions and Protiviti in recent quarterly commentary, and the market has begun to price in a scenario where hiring levels normalize rather than deteriorate further.
We are upgrading RHI to a buy for a long-term recovery trade. The setup is simple: buy at current levels to capture a mean reversion toward prior valuation multiples and the 52-week range high, while collecting a high quarterly payout. Risk is real — AI-driven disruption and slower corporate hiring are non-trivial — but the risk/reward looks attractive from here with a disciplined stop.
What the company does and why investors should care
Robert Half is a global provider of professional staffing and consulting — brands include Robert Half, Protiviti and several specialized recruiting divisions across finance, technology, creative and legal. The business comprises Contract Talent Solutions, Permanent Placement and Protiviti consulting. When corporate hiring rebounds, Robert Half benefits quickly via contract placements and consulting engagements; conversely, it is cyclical when budgets tighten.
Investors should care because this is a high-operating-leverage services model: small improvements in hiring activity and enterprise spending can drive outsized margin and cash-flow recovery. At the same time, RHI pays a meaningful quarterly dividend ($0.59 per share) which supports total return while waiting for a cyclical upswing.
Hard numbers that matter
| Metric | Value |
|---|---|
| Current price | $34.76 |
| Market cap | $3.56B |
| Reported EPS (trailing) | $1.27 |
| P/E | ~27.5x |
| P/B | ~2.9x |
| Dividend (quarterly) | $0.59 — yield roughly 7% |
| Free cash flow (latest) | $217.7M |
Put simply: market cap is modest at roughly $3.56 billion while the business still generates meaningful free cash flow ($217.7 million last reported). The yield and cash flow together make a defensive income cushion while the cyclical recovery plays out.
How the market has priced the cycle
Shares fell as much as 44% over the past year amid AI fears and a cooling hiring market. That selloff pushed valuation to a range where upside from normalization is significant. The stock currently trades below its prior 52-week high of $43.69 and around low-to-mid single-digit EV/sales multiples (enterprise value / sales ~0.62). Those multiples imply expectations of sustained weakness; if hiring and consulting spend normalize, multiples should re-rate closer to historical cyclical peers and prior ranges.
Technical picture supports a tactical entry
Momentum indicators have turned constructive: the 10-day and 20-day SMAs sit in the low $30s while the 50-day average has only recently lagged near $29. The 9-day EMA ($32.69) has crossed above the 21-day EMA, RSI is in the mid-60s, and MACD shows bullish momentum. These signs reduce the odds of an immediate fresh leg down and support a disciplined long entry around current levels.
Trade plan (actionable)
- Trade direction: Long
- Entry price: $34.75
- Stop loss: $29.50
- Target price: $42.00
- Horizon: long term (180 trading days) — hold up to ~180 trading days to allow the cyclical recovery and potential multiple expansion to play out. The dividend provides carry while waiting for price appreciation.
Rationale: $34.75 is near current market levels and captures the high dividend. A $29.50 stop limits downside to a contained level below recent support zones and credit-worthy free cash flow coverage. A $42 target sits inside the 52-week high and captures a re-rating toward prior cyclical peaks; if fundamentals improve more than expected, the position can be rolled or trimmed for additional upside.
Catalysts to drive the trade
- Continued sequential revenue improvement in Contract Talent Solutions and Protiviti as corporate hiring and enterprise consulting budgets normalize.
- Quarterly results that show sequential margin expansion or improved utilization in contract staffing — this is the primary operating lever.
- Positive guidance from management that sees year-over-year growth resuming in the back half of the fiscal period.
- Investor flows into beaten-down staffing names as macro data points to a softer landing and less hiring disruption than feared.
Risks and counterarguments
Every trade has clear risks; here are the most salient for RHI and why we still think the risk/reward is acceptable at the proposed entry.
- AI-driven structural headwinds: Automation and AI candidate-screening could reduce demand for certain white-collar placements, pressuring revenue and permanent placement fees. This is a legitimate long-term structural risk rather than a near-term cyclical one.
- Weaker-than-expected labor market: If corporate hiring weakens again, contract placements and consulting engagements could fall, prolonging the revenue trough and pushing shares lower.
- Multiple compression: Even with revenue stabilization, the market could re-price staffing companies to lower multiples due to secular concerns — that would limit upside even if fundamentals improve.
- Dividend sustainability: A high dividend yield is attractive, but should cash flows deteriorate meaningfully, the payout could be reduced — that would remove an important support for the share price.
Counterargument to the thesis: One could reasonably argue that Robert Half's decline is not just cyclical but structural — AI and internal HR tech will permanently shrink the addressable market for traditional staffing firms. If that thesis proves correct, RHI could underperform for years and the dividend might be at risk.
Why we remain constructive despite this: current free cash flow ($217.7 million) and a diversified business (including high-margin Protiviti consulting) provide time and optionality. The industry will evolve, but gaps in domain-specific hiring and complex consulting needs tend to favor specialty providers. We are not ignoring structural risk; rather, we size the position and use a stop to limit that exposure.
What would change our view
- If sequential revenue and utilization data reverse and show a sustained decline over two consecutive quarters, we would reduce or exit the position.
- If management cuts the dividend or significantly lowers guidance for Protiviti, that would signal the recovery is weaker than expected and prompt reassessment.
- If AI-related disruption results in accelerating permanent-placement share losses to new platforms (documented client attrition at scale), we would move to a neutral or short stance.
Conclusion
Robert Half is a classic cyclical with a defensive twist: it offers a high dividend and meaningful free cash flow while sitting at a valuation that assumes prolonged weakness. Recent sequential momentum and constructive technicals make a disciplined long attractive here for traders willing to hold for a recovery period of up to 180 trading days. Risk is real — particularly around AI and hiring trends — so keep position size moderate, use the $29.50 stop and monitor quarterly signals closely. If the company reports sustained sequential declines or cuts its dividend, we will change our view.
Trade idea snapshot: Buy RHI at $34.75, stop $29.50, target $42.00, horizon long term (180 trading days). Collect the dividend while the cyclical recovery unfolds.
Key monitoring checklist after entry
- Quarterly utilization and bill-rate trends in Contract Talent Solutions.
- Booking trends and margin trajectory at Protiviti.
- Management guidance and commentary on AI impact and client behavior.
- Macro hiring indicators and enterprise IT/consulting spend signals.